123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Technology,-Gadget-and-Science >> View Article

Branded Generics In South East Asia: Current And Future Opportunities

Profile Picture
By Author: Bharat Book
Total Articles: 682
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

With its fast-growing, young population and projected pharmaceutical sales in excess of $20 billion in 2014, countries in the Association of South East Asian Nations (ASEAN) represent a great opportunity for Pharma. http://www.bharatbook.com/healthcare-market-research-reports/branded-generics-in-south-east-asia-current-and-future-opportunities.html

However, with regional marketing practices, uncertain production values of locally manufactured generics and a huge diversity in healthcare delivery across ten nations of varying income levels, there are also great challenges.

Despite the disadvantages large multinationals face, major pharmaceutical companies are diving into the region, focusing on revenue from new chemical entities and developing ‘branded’ generics as key investments.

But given regional dynamics, pro-generic legislation, inconsistent IPR enforcement and local industry protection, what are the factors that the industry can leverage to drive success?

Report ...
... Overview
Based on interviews with ten of the region’s most experienced industry experts, Branded Generics in S.E. Asia: Current and Future Opportunities explores why the pharmaceutical industry is focusing on branded generics and new chemical entity (NCE) revenues. Timely and packed with essential details, the report describes the current state-of-play, the future of branded generics and the physician, prescriber and patient dynamics that govern drug dispensing.

By offering insight into the complex forces at work, this comprehensive report provides the critical intelligence necessary for success within the region. Can Big Pharma firmly insert itself into such a vibrant but locally-dominated market? Branded Generics in S.E. Asia: Current and Future Opportunities has the answers.

Key Report Features
Insight into why ASEAN markets are difficult for multinationals to penetrate
Timely, targeting information on regional dynamics
Discussion of ASEAN harmonization, how it is challenging regulatory and manufacturing standards and how that will impact local players
The role of government intervention, particularly in pro-generic legislation
The impact of local industry protection in creating barriers for multinationals
Strategies the industry is employing to take advantage of quality control legislation
Overview of regional economics

Who Would Benefit From This Report?
This report will be of value to senior pharma directors and managers with responsibilities in the following areas:
Executive management
Licensing/Business development
Market research and business intelligence
Marketing, category and product management
Key account and territory management
Emerging market development
Regulatory and government affairs

Key Questions Answered
What are the main challenges facing Big Pharma in South East Asia?
How can multinationals effectively gain traction in ASEAN countries?
Who is best adapting to regional conditions and how is it being done?
What are the conditions favouring local producers?
Who are the key decision makers and what are the factors influencing them?
How can multinationals adapt to changing government regulation?
What is the net benefit of establishing relationships with local companies?

Key Benefits
Gain insight into the complexity of the ASEAN region
Deepen your understanding of the current market situation in South East Asia
Find out how pro-generic legislation, local industry protection and manufacturing weaknesses have resulted in a lack of regional leaders
Gain insight into why most—but not all—local companies won’t survive ASEAN harmonization
Find out how success will be dependent upon quickly adapting to new regulatory standards and marketing the right branded generics to suit regional demographics
Receive insight into major commercial opportunities

For more information kindly visit :
Branded Generics in South East Asia: Current and Future Opportunities

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://in.linkedin.com/pub/bharat-book/3a/98/512
http://healthcareraj.blogspot.com/

Total Views: 344Word Count: 519See All articles From Author

Add Comment

Technology, Gadget and Science Articles

1. The Virtual Receptionist Service Is A Perfect Fit In The Ever-changing Work Dynamics!
Author: Eliza Garran

2. Choose Phone Answering Service Instead Of A Full-time In-house Receptionist
Author: Eliza Garran

3. Advanced Scrape Shake Shack Menu Prices And Calories Trends
Author: Web Data Crawler

4. Scrape Keeta Daily Restaurant Menus And Prices
Author: REAL DATA API

5. Web Scraping Sainsbury's Grocery Data For Price Optimization
Author: Web Data Crawler

6. Performance Testing & Load Optimization Services
Author: brainbell10

7. Yummi Nz Delivery Fee & Minimum Order Analysis | Part 5
Author: REAL DATA API

8. Why Choose Laser Diode Machine In India | Accuscan
Author: reveallasers

9. Extract Ramadan Meal Deals From Talabat & Deliveroo Uae
Author: Food Data Scraper

10. Product Growth Using Amazon Reviews Scraping Effectively
Author: Mellisa Torres

11. Migration To Jss Into Sitecore Content Sdk For Sitecore Ai
Author: Addact Technologies

12. Business Central Portal: Empowering Customers With Self-service Excellence
Author: crmjetty

13. Fintech Voucher & Cashback Data Collection - Cred Fintech Company
Author: Actowiz Solutions

14. Retail Business Intelligence: Cost-effective Alternatives To Tableau
Author: Vhelical

15. Operationalizing Ai At Scale: Why Llmops Is Now A Boardroom-level Priority
Author: James Eddie

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: